Presentation TCT 2019 Best Practices in Sterility Studies of Cardiovascular Devices: What Does the FDA Look For? Presenter: Hiren Mistry September 28, 2019 REGISTER for free or LOG IN to view this content Policy & Practice Presentation TCT 2019 Up Next Presentation TCT 2019 Best Practices in Biocompatibility Assessment of Cardiovascular Devices: What Does the FDA Look For? Presenter: Claire Hambright September 28, 2019 More slides + Presentation TCT 2019 LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease Presenter: Kenneth Ouriel September 28, 2019 Presentation TCT 2019 COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease — Importance of Revascularization Timing Presenter: David Wood September 28, 2019 We Recommend
Presentation TCT 2019 Best Practices in Biocompatibility Assessment of Cardiovascular Devices: What Does the FDA Look For? Presenter: Claire Hambright September 28, 2019
Presentation TCT 2019 LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease Presenter: Kenneth Ouriel September 28, 2019
Presentation TCT 2019 COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease — Importance of Revascularization Timing Presenter: David Wood September 28, 2019